BioCentury
ARTICLE | Company News

Elan in delivery deal with Targeted Molecules

November 16, 2000 8:00 AM UTC

ELN and Targeted (La Jolla, Calif.) will develop targeting technology for particles and certain drug conjugates in oncology. The deal combines Targeted's Angiomics Library of peptides that target spec...